Drug Abuse Testing Market: Size, Share, Trends, Analysis, Opportunity and Forecast 2022-2027
According to the latest report by IMARC Group, titled “Drug Abuse Testing Market: Global Industry Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the drug abuse testing market trends. The global drug abuse testing market size reached US$ 6.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.2 Billion by 2027, exhibiting a growth rate (CAGR) of 7.2% during 2022-2027.
Drug abuse represents the deliberate consumption of illegal substances or overindulgence of prescribed psychoactive and performance-enhancing chemicals and over-the-counter (OTC) medications. It can affect the body as well as the mind and lead to several disorders, including addiction. Consequently, drug abuse is diagnosed among individuals by using numerous testing methods to provide effective treatment for related disorders. In line with this, drug abuse testing aids in managing acute mental status and seizure cases in the emergency room and identifying children and newborns at risk of exposure to illicit drugs. Presently, it finds extensive applications in workplaces before hiring an applicant.
Request for a free sample copy of this report: https://www.imarcgroup.com/drug-abuse-testing-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Market Trends:
The widespread adoption of cannabinoids, cocaine, lysergic acid diethylamide (LSD), barbiturates, opiates, amphetamines, alcohol, diazepam, and ketamine for their non-therapeutic and medicinal uses, mind-altering characteristics, and other purposes, including weight loss and enhancing athletic performance is primarily driving the drug abuse testing market. Additionally, the growing number of pain management and opioid dependency clinics is further catalyzing the market growth. Besides this, drug abuse can create safety and health hazards and decrease the productivity and morale of an individual, which is propelling the demand for drug abuse testing to provide a safe workplace, screen employees and job applicants, comply with strict rules and regulations by government bodies, etc. Moreover, leading companies are providing automated testing and analysis and offering at-home use kits for instant drug abuse tests, thereby positively influencing the global market. Apart from this, the expanding e-commerce industry is anticipated to fuel the drug abuse testing market over the forecasted period.
Breakup by Product:
Analyzers
Immunoassays Analyzers
Chromatographic Devices
Breath Analyzers
Rapid Testing Devices
Urine Testing Devices
Oral Fluid Testing Devices
Consumables
Laboratory Services
Breakup by Sample:
Urine
Oral Fluid (Saliva)
Hair
Breath
Others
Breakup by End User:
Hospitals
Diagnostic Laboratories
Forensic Laboratories
Workplaces
Others
Breakup by Region:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
Competitive Landscape with Key Player:
Abbott Laboratories
Bio-Rad Laboratories Inc
Danaher Corporation
Drägerwerk AG & Co. KGaA
F. Hoffmann-La Roche AG
Laboratory Corporation of America Holdings
Omega Laboratories Inc
Quest Diagnostics Incorporated
Siemens AG
Thermo Fisher Scientific Inc
United States Drug Testing Laboratories Inc
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/drug-abuse-testing-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Related Reports:
Onychomycosis Treatment Market Report: https://www.imarcgroup.com/onychomycosis-treatment-market
Lateral Flow Assay Market Report: https://www.imarcgroup.com/lateral-flow-assay-market
Tissue Banking Market Report: https://www.imarcgroup.com/tissue-banking-market
Formulation Development Outsourcing Market Report: https://www.imarcgroup.com/formulation-development-outsourcing-market
Drug Device Combination Products Market Report: https://www.imarcgroup.com/drug-device-combination-products-market
Nanopore Technologies Market Report: https://www.imarcgroup.com/nanopore-technologies-market
United States DNA Sequencing Products Market Report: https://www.imarcgroup.com/united-states-dna-sequencing-products-market
Europe DNA Sequencing Products Market Report: https://www.imarcgroup.com/europe-dna-sequencing-products-market
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800